Methyl 5-fluoro-2-(methylamino)benzoate, 95.0%, 100mg

4-(N,N-Diethylaminocarbonyl)phenylboronic acid, 98.0%, 5g

Alcool benzylique, min 98 %, pour la synthèse, 2,5 L, emballage en verre

(S)-4-BOC-3-((S)-1-HYDROXYETHYL)MORPHOLINE, 97.0%, 250mg

Tulathromycin, 100mg

p-Hexyloxybromobenzene, 98.0%, 5g

3-Bromo-5-chloro-1-[(4-methylphenyl)sulfonyl]-1H-pyrrolo[2,3-b]pyridine, 95.0%, 100mg

(4-((2-Chlorobenzyl)carbamoyl)phenyl)boronic acid, 98%, 1g

((3-Bromophenyl)ethynyl)trimethylsilane, 95.0%, 10g

3,3'-(Ethane-1,2-diylbis(sulfanediyl))dipropanenitrile, 97%, 5g

(E)-N'-(3,5-Dibromo-2-hydroxybenzylidene)nicotinohydrazide, 97%, 1g

4-AMINO-N-METHYLPHENETHYLAMINE, 97.0%, 1g

2-Chloro-5-(5-Chloro-2-thienyl)pyridine, 97.0%, 1g